Life Science Nation (LSN) is a unique funding and partnering platform for early-stage life science companies in the biotech, medtech, diagnostics, and digital health sectors. The platform comprises two databases, with one tracking emerging life science companies and the other curating investors from around the world who are funding these entities. LSN also hosts the Redefining Early Stage Investments (RESI) Conference series and an I-Bank, Boston Innovation Capital (BIC), to facilitate matching up of buyers and sellers. RESI Conferences provide a venue for entrepreneurs to meet with 10 categories of investors that LSN tracks, including Family Offices, Corporate Venture Funds, Angel Groups, Venture Philanthropy, and Venture Capital. Through RESI Partnering, fundraising executives can have up to 16 scheduled meetings as well as many more ad-hoc meetings with diverse life science investors who fit their company’s technology sector, indication, and stage of development. The event also offers panels and workshops, providing attendees the opportunity to hear firsthand accounts from investors explaining their current investment mandates and process for identifying and qualifying candidates. Founded in 2012, Life Science Nation primarily operates in the Health Care and Life Sciences industries. The platform is dedicated to connecting products, services, and capital for the advancement of early-stage life science companies. With its focus on #LifeScience, #FundraisingEvent, #InvestorRelations, #Partnering, and #Investment, Life Science Nation has created a valuable niche in the industry.
There is no investment information
No recent news or press coverage available for Life Science Nation.